Quantifying the Social Costs of Pharmaceutical Opioid Misuse & Illicit Opioid Use to Australia in 2015/16

Steve Whetton; Robert Tait; Agata Chrzanowska; Neil Donnelly; Alice McEntee; Aqif  Mukhtar; Emma Zahra; Gabrielle Campbell; Louisa Degenhardt; Tania Dey; Suraya Abdul Halim; Wayne Hall; Marshall Makate; Richard Norman; Amy Peacock; Ann Roche; Steve Allsop

Quantifying the Social Costs of Pharmaceutical Opioid Misuse & Illicit Opioid Use to Australia in 2015/16

Steve Whetton, Robert Tait, Agata Chrzanowska, Neil Donnelly, Alice McEntee, Aqif Mukhtar, Emma Zahra, Gabrielle Campbell, Louisa Degenhardt, Tania Dey, Suraya Abdul Halim, Wayne Hall, Marshall Makate, Richard Norman, Amy Peacock, Ann Roche, Steve Allsop

Research output: Book/Report › Commissioned report

Abstract

In recent decades the range and patterns of opioids used for extra-medical purposes have changed. The use of pharmaceutical opioids exceeds the use of heroin. In 2017, 63 percent of opioid deaths were attributed exclusively to pharmaceutical opioids, 28 percent to illicit opioids and 8 percent to both illicit and pharmaceutical opioids (aged 15-64 years) (Chrzanowska et al., 2019). The extra-medical use of opioids is also likely to result in other adverse outcomes including those that: require the use of health services; reduce work productivity; or, result in contact with the criminal justice system.

Original language	English
Place of Publication	Perth, Western Australia
Publisher	National Drug Research Institute
Number of pages	198
ISBN (Print)	978-0-6487367-0-7
Publication status	Published - Feb 2020

Keywords

Pharmaceutical misuse
opioid misuse
illicit drug use
social costs

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

https://www.atdc.org.au/quantifying-the-social-costs-of-pharmaceutical-opioid-misuse-illicit-opioid-use-to-australia-in-2015-16/Licence: In Copyright

Cite this

Whetton, S., Tait, R., Chrzanowska, A., Donnelly, N., McEntee, A., Mukhtar, A., Zahra, E., Campbell, G., Degenhardt, L., Dey, T., Halim, S. A., Hall, W., Makate, M., Norman, R., Peacock, A., Roche, A., & Allsop, S. (2020). Quantifying the Social Costs of Pharmaceutical Opioid Misuse & Illicit Opioid Use to Australia in 2015/16. National Drug Research Institute. https://www.atdc.org.au/quantifying-the-social-costs-of-pharmaceutical-opioid-misuse-illicit-opioid-use-to-australia-in-2015-16/

@book{7863709f1c654876b2ba42ae696bd4f4,

title = "Quantifying the Social Costs of Pharmaceutical Opioid Misuse & Illicit Opioid Use to Australia in 2015/16",

abstract = "In recent decades the range and patterns of opioids used for extra-medical purposes have changed. The use of pharmaceutical opioids exceeds the use of heroin. In 2017, 63 percent of opioid deaths were attributed exclusively to pharmaceutical opioids, 28 percent to illicit opioids and 8 percent to both illicit and pharmaceutical opioids (aged 15-64 years) (Chrzanowska et al., 2019). The extra-medical use of opioids is also likely to result in other adverse outcomes including those that: require the use of health services; reduce work productivity; or, result in contact with the criminal justice system.",

keywords = "Pharmaceutical misuse, opioid misuse, illicit drug use, social costs",

author = "Steve Whetton and Robert Tait and Agata Chrzanowska and Neil Donnelly and Alice McEntee and Aqif Mukhtar and Emma Zahra and Gabrielle Campbell and Louisa Degenhardt and Tania Dey and Halim, {Suraya Abdul} and Wayne Hall and Marshall Makate and Richard Norman and Amy Peacock and Ann Roche and Steve Allsop",

year = "2020",

month = feb,

language = "English",

isbn = "978-0-6487367-0-7",

publisher = "National Drug Research Institute",

}

Whetton, S, Tait, R, Chrzanowska, A, Donnelly, N, McEntee, A, Mukhtar, A, Zahra, E, Campbell, G, Degenhardt, L, Dey, T, Halim, SA, Hall, W, Makate, M, Norman, R, Peacock, A, Roche, A & Allsop, S 2020, Quantifying the Social Costs of Pharmaceutical Opioid Misuse & Illicit Opioid Use to Australia in 2015/16. National Drug Research Institute, Perth, Western Australia. <https://www.atdc.org.au/quantifying-the-social-costs-of-pharmaceutical-opioid-misuse-illicit-opioid-use-to-australia-in-2015-16/>

TY - BOOK

T1 - Quantifying the Social Costs of Pharmaceutical Opioid Misuse & Illicit Opioid Use to Australia in 2015/16

AU - Whetton, Steve

AU - Tait, Robert

AU - Chrzanowska, Agata

AU - Donnelly, Neil

AU - McEntee, Alice

AU - Mukhtar, Aqif

AU - Zahra, Emma

AU - Campbell, Gabrielle

AU - Degenhardt, Louisa

AU - Dey, Tania

AU - Halim, Suraya Abdul

AU - Hall, Wayne

AU - Makate, Marshall

AU - Norman, Richard

AU - Peacock, Amy

AU - Roche, Ann

AU - Allsop, Steve

PY - 2020/2

Y1 - 2020/2

N2 - In recent decades the range and patterns of opioids used for extra-medical purposes have changed. The use of pharmaceutical opioids exceeds the use of heroin. In 2017, 63 percent of opioid deaths were attributed exclusively to pharmaceutical opioids, 28 percent to illicit opioids and 8 percent to both illicit and pharmaceutical opioids (aged 15-64 years) (Chrzanowska et al., 2019). The extra-medical use of opioids is also likely to result in other adverse outcomes including those that: require the use of health services; reduce work productivity; or, result in contact with the criminal justice system.

AB - In recent decades the range and patterns of opioids used for extra-medical purposes have changed. The use of pharmaceutical opioids exceeds the use of heroin. In 2017, 63 percent of opioid deaths were attributed exclusively to pharmaceutical opioids, 28 percent to illicit opioids and 8 percent to both illicit and pharmaceutical opioids (aged 15-64 years) (Chrzanowska et al., 2019). The extra-medical use of opioids is also likely to result in other adverse outcomes including those that: require the use of health services; reduce work productivity; or, result in contact with the criminal justice system.

KW - Pharmaceutical misuse

KW - opioid misuse

KW - illicit drug use

KW - social costs

M3 - Commissioned report

SN - 978-0-6487367-0-7

BT - Quantifying the Social Costs of Pharmaceutical Opioid Misuse & Illicit Opioid Use to Australia in 2015/16

PB - National Drug Research Institute

CY - Perth, Western Australia

ER -

Quantifying the Social Costs of Pharmaceutical Opioid Misuse & Illicit Opioid Use to Australia in 2015/16

Abstract

Keywords

UN SDGs

Access to Document

Fingerprint

Cite this